VIAMAL

This brand name is authorized in Malta.

Active ingredients

The drug VIAMAL contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Diethylamine salicylate UNII `5V7PT38BJU` - DIETHYLAMINE SALICYLATE
	Diethylamine salicylate is a topical analgesic, with the anti-inflammatory properties of salicylates. It is believed to exert cortisone-like action, stimulating the pituitary-adrenal axis, exerting an analgesic and anti-inflammatory effect.
	Read more about Diethylamine salicylate
`2`	Heparin UNII `ZZ45AB24CA` - HEPARIN SODIUM
	Heparin is an anticoagulant and acts by inhibiting thrombin and by potentiating the naturally occurring inhibitors of activated Factor X (Xa).
	Read more about Heparin
`3`	Menthol UNII `L7T10EIP3A` - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AC	Preparations with salicylic acid derivatives	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	AA729/28001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.